Cite
HARVARD Citation
Moore, A. et al. (n.d.). P411 Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching program. Journal of Crohn's and colitis. pp. i401-i402. [Online].